Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gasperini

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of the Neurological Sciences|April 1, 1993
Anatomical and functional correlates of cognitive deficit in multiple sclerosisC Pozzilli, C Gasperini, A Anzini, et al.
Acta Neurologica Scandinavica|September 2, 1998
MRI evolution of new MS lesions enhancing after different doses of gadoliniumM Rovaris, G Mastronardo, C Gasperini, et al.
European Journal of Neurology|June 11, 1999
Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosisO Ciccarelli, E Giugni, A Paolillo, et al.
Journal of the Neurological Sciences|May 1, 1999
Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trialsM P Sormani, P Bruzzi, D H Miller, et al.
Journal of Neuroimmunology|August 4, 1998
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosisG Ristori, F Laurenti, P Stacchini, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 29, 1998
A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosisM Filippi, M Rovaris, C Gasperini, et al.
Journal of Neurology|August 25, 1999
Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imagingC Tortorella, M Codella, M A Rocca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosisC Gasperini, M Rovaris, M P Sormani, et al.
Magnetic Resonance Imaging|August 10, 2000
A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosisC Gasperini, A Paolillo, M Rovaris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
Antinuclear antibodies and response to IFNbeta-1a therapy in relapsing-remitting multiple sclerosisO Ciccarelli, F Bagnato, C Mainero, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of the Neurological Sciences|April 1, 1993
Anatomical and functional correlates of cognitive deficit in multiple sclerosisC Pozzilli, C Gasperini, A Anzini, et al.
Acta Neurologica Scandinavica|September 2, 1998
MRI evolution of new MS lesions enhancing after different doses of gadoliniumM Rovaris, G Mastronardo, C Gasperini, et al.
European Journal of Neurology|June 11, 1999
Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosisO Ciccarelli, E Giugni, A Paolillo, et al.
Journal of the Neurological Sciences|May 1, 1999
Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trialsM P Sormani, P Bruzzi, D H Miller, et al.
Journal of Neuroimmunology|August 4, 1998
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosisG Ristori, F Laurenti, P Stacchini, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 29, 1998
A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosisM Filippi, M Rovaris, C Gasperini, et al.
Journal of Neurology|August 25, 1999
Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imagingC Tortorella, M Codella, M A Rocca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2001
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosisC Gasperini, M Rovaris, M P Sormani, et al.
Magnetic Resonance Imaging|August 10, 2000
A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosisC Gasperini, A Paolillo, M Rovaris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
Antinuclear antibodies and response to IFNbeta-1a therapy in relapsing-remitting multiple sclerosisO Ciccarelli, F Bagnato, C Mainero, et al.
Pageof 10